Slide 1 Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven, Belgium On…

Slide 1 DIAGNOSTIC BIOMARKERS FOR COLORECTAL CANCER Identifying Protein based Serum & Plasma Biomarkers using a Proteomics-based Approach Ms. Aisha Q. Butt Prof. Martin…

Slide 1 Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven, Belgium On…

Slide 1 Results of a phase III randomized, double-blind, placebo-controlled, multicenter trial (CORRECT) of regorafenib plus best supportive care (BSC) versus placebo plus…

Objectives Participants will be able to: Identify the characteristics of their local uninsured population over 50 years of age Arrange primary care screening for those over…